Search

Author/Creator Elfont, Robert

1. A Phase 3, double-blind, placebo-controlled efficacy and safety study of ADS-5102 (Amantadine) extended-release capsules in people with multiple sclerosis and walking impairment. (April 2022)

Authors:
Cohen, Jeffrey A; Cameron, Michelle H; Goldman, Myla D; Goodman, Andrew D; Miller, Aaron E; Rollins, Anne; Llorens, Lily; Patni, Rajiv; Elfont, Robert; Johnson, Reed
Journal:
Multiple sclerosis
Issue:
Volume 28:Number 5(2022)
Page Start:
817
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Abstracts from the Food Allergy and Anaphylaxis Meeting 2016. (30th March 2017)

Authors:
Pouessel, Guillaume; Claverie, Claire; Labreuche, Julien; Renaudin, Jean‐Marie; Dorkenoo, Aimée; Eb, Mireille; Moneret‐Vautrin, Anne; Deschildre, Antoine; Leteurtre, Stephane; Grabenhenrich, Linus; Worm, Margitta; Dölle, Sabine; Scherer, Kathrin; Hutteger, Isidor; Christensen, Morten; Bindslev‐Je...
Journal:
Clinical and translational allergy
Issue:
Volume 7:(2017)Supplement 1
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search